153 related articles for article (PubMed ID: 23368859)
1. Prospective and retrospective review of gynecologic cytopathology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 2.
Brainard JA; Birdsong GG; Elsheikh TM; Hartley DA; Naik K; Neal MH; Souers RJ; Henry MR
Arch Pathol Lab Med; 2013 Feb; 137(2):175-82. PubMed ID: 23368859
[TBL] [Abstract][Full Text] [Related]
2. Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.
Booth CN; Bashleben C; Filomena CA; Means MM; Wasserman PG; Souers RJ; Henry MR
Arch Pathol Lab Med; 2013 Feb; 137(2):214-9. PubMed ID: 23368863
[TBL] [Abstract][Full Text] [Related]
3. Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4.
Crothers BA; Jones BA; Cahill LA; Moriarty AT; Mody DR; Tench WD; Souers RJ
Arch Pathol Lab Med; 2013 Feb; 137(2):199-213. PubMed ID: 23368862
[TBL] [Abstract][Full Text] [Related]
4. College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference on good laboratory practices in gynecologic cytology: background, rationale, and organization.
Tworek JA; Henry MR; Blond B; Jones BA
Arch Pathol Lab Med; 2013 Feb; 137(2):158-63. PubMed ID: 23368857
[TBL] [Abstract][Full Text] [Related]
5. General quality practices in gynecologic cytopathology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 3.
Tworek J; Nayar R; Savaloja L; Tabbara S; Thomas N; Winkler B; Howell LP
Arch Pathol Lab Med; 2013 Feb; 137(2):190-8. PubMed ID: 23368861
[TBL] [Abstract][Full Text] [Related]
6. The role of monitoring interpretive rates, concordance between cytotechnologist and pathologist interpretations before sign-out, and turnaround time in gynecologic cytology quality assurance: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 1.
Clary KM; Davey DD; Naryshkin S; Austin RM; Thomas N; Chmara BA; Sugrue C; Tworek J
Arch Pathol Lab Med; 2013 Feb; 137(2):164-74. PubMed ID: 23368858
[TBL] [Abstract][Full Text] [Related]
7. The role of proficiency testing in ensuring quality: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 3.
Howell LP; Nayar R; Savaloja L; Tabbara S; Thomas N; Winkler B; Tworek J
Arch Pathol Lab Med; 2013 Feb; 137(2):183-9. PubMed ID: 23368860
[TBL] [Abstract][Full Text] [Related]
8. Rescreening in gynecologic cytology. Rescreening of 8096 previous cases for current low-grade and indeterminate-grade squamous intraepithelial lesion diagnoses--a College of American Pathologists Q-Probes study of 323 laboratories.
Jones BA
Arch Pathol Lab Med; 1996 Jun; 120(6):519-22. PubMed ID: 8651851
[TBL] [Abstract][Full Text] [Related]
9. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
[TBL] [Abstract][Full Text] [Related]
10. Rescreening Practices of Negative Papanicolaou Tests With Positive Human Papillomavirus Test Result.
Goyal A; Davey DD; Souers RJ; Tabbara SO; Goodrich K; Booth CN
Arch Pathol Lab Med; 2022 Jan; 146(1):78-83. PubMed ID: 33929528
[TBL] [Abstract][Full Text] [Related]
11. Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.
Sturgis CD; Schaaf MR; Tickman RJ
Diagn Cytopathol; 2013 May; 41(5):399-403. PubMed ID: 22351303
[TBL] [Abstract][Full Text] [Related]
12. Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.
Eversole GM; Moriarty AT; Schwartz MR; Clayton AC; Souers R; Fatheree LA; Chmara BA; Tench WD; Henry MR; Wilbur DC
Arch Pathol Lab Med; 2010 Mar; 134(3):331-5. PubMed ID: 20196659
[TBL] [Abstract][Full Text] [Related]
13. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure.
Tabbara SO; Sidawy MK
Diagn Cytopathol; 1996 Feb; 14(1):84-6. PubMed ID: 8834084
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey.
Zhao C; Crothers BA; Ghofrani M; Li Z; Souers RJ; Hussain M; Fan F; Ocal IT; Goodrich K; Shen R; Davey DD;
Arch Pathol Lab Med; 2016 Dec; 140(12):1364-1370. PubMed ID: 27479334
[TBL] [Abstract][Full Text] [Related]
16. Bethesda 2014 Implementation and Human Papillomavirus Primary Screening: Practices of Laboratories Participating in the College of American Pathologists PAP Education Program.
Davey DD; Souers RJ; Goodrich K; Mody DR; Tabbara SO; Booth CN
Arch Pathol Lab Med; 2019 Oct; 143(10):1196-1202. PubMed ID: 31021657
[TBL] [Abstract][Full Text] [Related]
17. False-positive Papanicolaou (PAP) test rates in the College of American Pathologists PAP education and PAP proficiency test programs: evaluation of false-positive responses of high-grade squamous intraepithelial lesion or cancer to a negative reference diagnosis.
Crothers BA; Booth CN; Darragh TM; Zhao C; Souers RJ; Thomas N; Moriarty AT
Arch Pathol Lab Med; 2014 May; 138(5):613-9. PubMed ID: 24786119
[TBL] [Abstract][Full Text] [Related]
18. NILM Pap slides from women 30 years of age and older with positive high-risk HPV DNA. Focused rescreening prior to report issuance, an enhanced quality control measure.
Cormier K; Schaaf M; Hamilton S; Tickman RJ; Perez-Reyes N; Sturgis CD
Am J Clin Pathol; 2014 Apr; 141(4):494-500. PubMed ID: 24619749
[TBL] [Abstract][Full Text] [Related]
19. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
20. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
